World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
112
Citations
41510
World Ranking
5185
National Ranking
283

Overview

Hans-Jürgen Wester is affiliated with the Technical University of Munich in Germany. Their research is focused predominantly within the field of Medicine, with a particular emphasis on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology, Epidemiology, and Molecular Biology.

The scientist's main topics of work include Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research, Peptidase Inhibition and Analysis, Neuroendocrine Tumor Research Advances, Prostate Cancer Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, and Chemokine Receptors and Signaling.

Recent papers published by Hans-Jürgen Wester are as follows:

  • PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0, 2023, European Journal of Nuclear Medicine and Molecular Imaging
  • Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms using 68Ga-PentixaFor PET, 2022, Journal of Nuclear Medicine
  • Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non-Tumor-Related Uptake and Tumor Positivity, 2020, Journal of Nuclear Medicine
  • A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency, 2020, Theranostics
  • Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT, 2021, Journal of Nuclear Medicine

Frequent coauthors collaborating with Hans-Jürgen Wester include:

  • Constantin Lapa
  • Alexander Wurzer
  • Wolfgang Weber
  • Roswitha Beck
  • Thomas Günther

The scientist has a significant publication record in several journals, with the most frequent venues being:

  • Journal of Nuclear Medicine
  • EJNMMI Research
  • European Journal of Nuclear Medicine and Molecular Imaging
  • EJNMMI Radiopharmacy and Chemistry
  • Pharmaceuticals

Best Publications

  • Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

    Matthias Eiber;Tobias Maurer;Michael Souvatzoglou;Ambros J. Beer

  • Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer

    Tobias Maurer;Jürgen E. Gschwend;Isabel Rauscher;Michael Souvatzoglou

  • Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography

    Roland Haubner;Hans-Jürgen Wester;Wolfgang A. Weber;Christian Mang

  • 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.

    Wolfgang P. Fendler;Wolfgang P. Fendler;Matthias Eiber;Matthias Eiber;Mohsen Beheshti;Jamshed Bomanji

  • Glycosylated RGD-Containing Peptides: Tracer for Tumor Targeting and Angiogenesis Imaging with Improved Biokinetics

    Roland Haubner;Hans-Jürgen Wester;Fred Burkhart;Reingard Senekowitsch-Schmidtke

  • Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGD

    Roland Haubner;Wolfgang A Weber;Ambros J Beer;Eugenija Vabuliene

  • Radiolabeled αvβ3 Integrin Antagonists: A New Class of Tracers for Tumor Targeting

    Roland Haubner;Hans-Jürgen Wester;Ute Reuning;Reingard Senekowitsch-Schmidtke

  • Simultaneous 68 Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer

    Matthias Eiber;Gregor Weirich;Konstantin Holzapfel;Michael Souvatzoglou

  • A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins.

    Tobias G. Kapp;Florian Rechenmacher;Stefanie Neubauer;Oleg V. Maltsev

  • 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies

    Martina Weineisen;Margret Schottelius;Jakub Simecek;Richard P Baum

  • O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study.

    Wolfgang A. Weber;Hans-Jürgen Wester;Anca L. Grosu;Michael Herz

  • 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy

    Richard P Baum;Harshad R Kulkarni;Christiane Schuchardt;Aviral Singh

  • Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in Man

    Ambros J. Beer;Roland Haubner;Mario Sarbia;Michael Goebel

  • [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates.

    Roland Haubner;Bertrand Kuhnast;Christian Mang;Wolfgang A Weber

  • THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors

    Stephen P.H. Alexander;Arthur Christopoulos;Anthony P. Davenport;Eamonn Kelly

  • Hypoxia-Specific Tumor Imaging with 18F-Fluoroazomycin Arabinoside

    Morand Piert;Hans Jürgen Machulla;Maria Picchio;Gerald Reischl

  • Exploring the Role of RGD-Recognizing Integrins in Cancer.

    Markus Nieberler;Ute Reuning;Florian Reichart;Johannes Notni

  • Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs.

    Thorsten Poethko;Margret Schottelius;Georgette Thumshirn;Ulrich Hersel

  • Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients.

    Ambros J. Beer;Roland Haubner;Michael Goebel;Stephan Luderschmidt

  • Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.

    Peter Heiss;Sabine Mayer;Michael Herz;Hans-Jürgen Wester

Frequent Co-Authors

Markus Schwaiger
Markus Schwaiger Technical University of Munich
Horst Kessler
Horst Kessler Technical University of Munich
Ken Herrmann
Ken Herrmann German Cancer Research Center
Tobias Maurer
Tobias Maurer University Medical Center Hamburg-Eppendorf
Frank M. Bengel
Frank M. Bengel Hannover Medical School
Alexander Drzezga
Alexander Drzezga University of Cologne
Christian Peschel
Christian Peschel Technical University of Munich
Stephan G. Nekolla
Stephan G. Nekolla Technical University of Munich
Wolfgang A. Weber
Wolfgang A. Weber Technical University of Munich
Timo Grimmer
Timo Grimmer Technical University of Munich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees opens up a wide range of career options alongside traditional medical school paths. For those interested in healthcare management, online mha programs cahme accredited offer flexible, reputable training for leadership roles in hospitals and health systems.

Registered nurses seeking advancement can consider an rn to bsn online with no clinicals program, allowing completion of a bachelor’s degree without additional on-site requirements. Nurse practitioners and advanced nurses can fast-track their learning through dnp programs online, some of which also offer accelerated curriculums.

For added convenience, it’s possible to find a dnp program without clinical hours, providing an academic route with minimal on-site commitments. These alternatives are valuable for working professionals or those looking for less traditional pathways to impactful healthcare careers.

Best Scientists Citing Hans-Jürgen Wester

Trending Scientists

Recently Published Articles